دورية أكاديمية

The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.

التفاصيل البيبلوغرافية
العنوان: The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.
المؤلفون: VanderZwaag, Jared, Halvorson, Torin, Dolhan, Kira, Šimončičová, Eva, Ben-Azu, Benneth, Tremblay, Marie-Ève
المصدر: Neurochemical Research; Apr2023, Vol. 48 Issue 4, p1129-1166, 38p
مصطلحات موضوعية: LSD (Drug), PSILOCYBIN, INTRAVENOUS anesthetics, MICROGLIA, KETAMINE, HALLUCINOGENIC drugs, NEUROGLIA
مستخلص: There is much excitement surrounding recent research of promising, mechanistically novel psychotherapeutics – psychedelic, anesthetic, and dissociative agents – as they have demonstrated surprising efficacy in treating central nervous system (CNS) disorders, such as mood disorders and addiction. However, the mechanisms by which these drugs provide such profound psychological benefits are still to be fully elucidated. Microglia, the CNS's resident innate immune cells, are emerging as a cellular target for psychiatric disorders because of their critical role in regulating neuroplasticity and the inflammatory environment of the brain. The following paper is a review of recent literature surrounding these neuropharmacological therapies and their demonstrated or hypothesized interactions with microglia. Through investigating the mechanism of action of psychedelics, such as psilocybin and lysergic acid diethylamide, ketamine, and propofol, we demonstrate a largely under-investigated role for microglia in much of the emerging research surrounding these pharmacological agents. Among others, we detail sigma-1 receptors, serotonergic and γ-aminobutyric acid signalling, and tryptophan metabolism as pathways through which these agents modulate microglial phagocytic activity and inflammatory mediator release, inducing their therapeutic effects. The current review includes a discussion on future directions in the field of microglial pharmacology and covers bidirectional implications of microglia and these novel pharmacological agents in aging and age-related disease, glial cell heterogeneity, and state-of-the-art methodologies in microglial research. [ABSTRACT FROM AUTHOR]
Copyright of Neurochemical Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03643190
DOI:10.1007/s11064-022-03772-0